Publications

Vlahou A, Hallinan D, Apweiler R, Argiles A, Beige J, Benigni A, Bischoff R, Black PC, Boehm F, Céraline J, Chrousos GP, Delles C, Evenepoel P, Fridolin I, Glorieux G, van Gool AJ, Heidegger I, Ioannidis JPA, Jankowski J, Jankowski V, Jeronimo C, Kamat AM, Masereeuw R, Mayer G, Mischak H, Ortiz A, Remuzzi G, Rossing P, Schanstra JP, Schmitz-Dräger BJ, Spasovski G, Staessen JA, Stamatialis D, Stenvinkel P, Wanner C, Williams SB, Zannad F, Zoccali C, Vanholder R. Data Sharing Under the General Data Protection Regulation: Time to Harmonize Law and Research Ethics? (2021) Hypertension, 77(4):1029-1035. doi: 10.1161/HYPERTENSIONAHA.120.16340. Epub 2021 Feb 15.

He T, Melgarejo JD, Clark AL, Yu YL, Thijs L, Díez J, López B, González A, Cleland JG, Schanstra JP, Vlahou A, Latosinska A, Mischak H, Staessen JA, Zhang ZY, Jankowski V. Serum and urinary biomarkers of collagen type-I turnover predict prognosis in patients with heart failure. (2021) Clin Transl Med., 11(1):e267. doi: 10.1002/ctm2.267.

Nikolaou PE, Efentakis P, Abu Qourah F, Femminò S, Makridakis M, Kanaki Z, Varela A, Tsoumani M, Davos CH, Dimitriou CA, Tasouli A, Dimitriadis G, Kostomitsopoulos N, Zuurbier CJ, Vlahou A, Klinakis A, Brizzi MF, Iliodromitis EK, Andreadou I. Chronic Empagliflozin Treatment Reduces Myocardial Infarct Size in Nondiabetic Mice Through STAT-3-Mediated Protection on Microvascular Endothelial Cells and Reduction of Oxidative Stress. (2021) Antioxid Redox Signal., 34(7):551-571. doi: 10.1089/ars.2019.7923.

Frantzi M, Latosinska A, Mokou M, Mischak H, Vlahou A. Drug repurposing in oncology.
(2020) Lancet Oncol., 21(12):e543. doi: 10.1016/S1470-2045(20)30610-0.

Mokou M, Lygirou V, Angelioudaki I, Paschalidis N, Stroggilos R, Frantzi M, Latosinska A, Bamias A, Hoffmann MJ, Mischak H, Vlahou A. A Novel Pipeline for Drug Repurposing for Bladder Cancer Based on Patients' Omics Signatures. (2020) Cancers (Basel), 26;12(12):3519. doi: 10.3390/cancers12123519.

Makridakis, M., Kontostathi, G., Petra, E., Stroggilos, R., Lygirou, V., Filip, S., Duranton, F., Mischak, H., Argiles, A., Zoidakis, J., Vlahou, A. Multiplexed MRM-based protein quantification of putative prognostic biomarkers for chronic kidney disease progression in plasma (2020) Scientific Reports, 10 (1), art. no. 4815, DOI: 10.1038/s41598-020-61496-z

Mantsiou, A., Makridakis, M., Fasoulakis, K., Katafigiotis, I., Constantinides, C.A., Zoidakis, J., Roubelakis, M.G., Vlahou, A., Lygirou, V. Proteomics Analysis of Formalin Fixed Paraffin Embedded Tissues in the Investigation of Prostate Cancer (2020) Journal of Proteome Research, 19 (7), pp. 2631-2642. DOI: 10.1021/acs.jproteome.9b00587

Stroggilos, R., Mokou, M., Latosinska, A., Makridakis, M., Lygirou, V., Mavrogeorgis, E., Drekolias, D., Frantzi, M., Mullen, W., Fragkoulis, C., Stasinopoulos, K., Papadopoulos, G., Stathouros, G., Lazaris, A.C., Makrythanasis, P., Ntoumas, K., Mischak, H., Zoidakis, J., Vlahou, A. Proteome-based classification of Nonmuscle Invasive Bladder Cancer (2020) International Journal of Cancer, 146 (1), pp. 281-294. DOI: 10.1002/ijc.32556

Zagoura, D., Trohatou, O., Makridakis, M., Kollia, A., Kokla, N., Mokou, M., Psaraki, A., Eliopoulos, A.G., Vlahou, A., Roubelakis, M.G. Functional secretome analysis reveals Annexin-A1 as important paracrine factor derived from fetal mesenchymal stem cells in hepatic regeneration (2019) EBioMedicine, 45, pp. 542-552. DOI: 10.1016/j.ebiom.2019.07.009

Chasapis, C.T., Makridakis, M., Damdimopoulos, A.E., Zoidakis, J., Lygirou, V., Mavroidis, M., Vlahou, A., Miranda-Vizuete, A., Spyrou, G., Vlamis-Gardikas, A. Implications of the mitochondrial interactome of mammalian thioredoxin 2 for normal cellular function and disease (2019) Free Radical Biology and Medicine, 137, pp. 59-73.  DOI: 10.1016/j.freeradbiomed.2019.04.018

Mokou, M., Klein, J., Makridakis, M., Bitsika, V., Bascands, J.-L., Saulnier-Blache, J.S., Mullen, W., Sacherer, M., Zoidakis, J., Pieske, B., Mischak, H., Roubelakis, M.G., Schanstra, J.P., Vlahou, A. Proteomics based identification of KDM5 histone demethylases associated with cardiovascular disease(2019) EBioMedicine, 41, pp. 91-104. DOI: 10.1016/j.ebiom.2019.02.040

Schanstra, J.P., Luong, T.T.D., Makridakis, M., Van Linthout, S., Lygirou, V., Latosisnska, A., Alesutan, I., Boehme, B., Schelski, N., Von Lewinski, D., Mullen, W., Nicklin, S., Delles, C., Feuillet, G., Denis, C., Lang, F., Pieske, B., Bascands, J.-L., Mischak, H., Saulnier-Blache, J.-S., Voelkl, J., Vlahou, A*., Klein, J. Systems biology identifies cytosolic PLA2 as a target in vascular calcification treatment (2019) JCI Insight, 4 (10), art. no. e125638 DOI: 10.1172/jci.insight.125638 (*equal contributing last author)

Luong, T.T.D., Schelski, N., Boehme, B., Makridakis, M., Vlahou, A., Lang, F., Pieske, B., Alesutan, I., Voelkl, J. Fibulin-3 Attenuates Phosphate-Induced Vascular Smooth Muscle Cell Calcification by Inhibition of Oxidative Stress (2018) Cellular Physiology and Biochemistry, 46 (4), pp. 1305-1316.  DOI: 10.1159/000489144

Lygirou, V., Latosinska, A., Makridakis, M., Mullen, W., Delles, C., Schanstra, J.P., Zoidakis, J., Pieske, B., Mischak, H., Vlahou, A. Plasma proteomic analysis reveals altered protein abundances in cardiovascular disease (2018) Journal of Translational Medicine, 16 (1), art. no. 104, DOI: 10.1186/s12967-018-1476-9